Related Experiment Videos
Dynamic changes in p27kip1 variant expression in activated lymphocytes
B Yaroslavskiy1, S C Watkins, S Alber
1Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA.
Journal of Cellular Biochemistry
|October 12, 2001
Summary
A new variant of the p27Kip1 cell cycle inhibitor (p27) is rapidly degraded upon lymphocyte activation. However, full-length p27 persists, indicating cell cycle entry doesn't require complete p27 elimination.
Area of Science:
- Cell Biology
- Immunology
- Molecular Biology
Background:
- The p27Kip1 protein (p27) is a key regulator of cellular growth.
- Understanding how cell cycle inhibitors are modulated during immune cell activation is crucial.
Purpose of the Study:
- To investigate the expression and regulation of p27 variants in activated lymphocytes.
- To determine the role of p27 degradation in lymphocyte cell cycle entry.
Main Methods:
- Analysis of p27 variant expression in peripheral blood lymphocytes.
- Assessment of p27 degradation kinetics upon activation with interleukin-2 or superantigen.
- Proteasome inhibition assays.
- Immunofluorescence to determine protein localization.
Main Results:
- A 24 kD C-terminal variant of p27 (p24) is expressed in resting lymphocytes.
- p24 undergoes rapid, proteasome-dependent degradation following lymphocyte activation.
- Full-length p27 levels decrease modestly and persist in activated, cycling lymphocytes.
- Persistent p27 forms a complex with cyclin D3 and localizes to both nucleus and cytoplasm.
Conclusions:
- Lymphocytes employ multiple strategies to overcome p27Kip1-mediated cell cycle checkpoints during activation.
- Complete elimination of p27 is not a prerequisite for cell cycle entry in activated lymphocytes.
- Differential regulation of p27 variants plays a role in controlling lymphocyte proliferation.